Institute of Legal Medicine, University Hospital Frankfurt, Goethe University, Kennedyallee 104, 60596, Frankfurt am Main, Germany.
Institute of Medical Virology, University Hospital Frankfurt, Goethe University, Paul-Ehrlich-Straße 40, 60596, Frankfurt am Main, Germany.
Int J Legal Med. 2021 Sep;135(5):2055-2060. doi: 10.1007/s00414-021-02546-7. Epub 2021 Mar 5.
The duration of infectivity of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) in living patients has been demarcated. In contrast, a possible SARS-CoV-2 infectivity of corpses and subsequently its duration under post mortem circumstances remain to be elucidated. The aim of this study was to investigate the infectivity and its duration of deceased COVID-19 (coronavirus disease) patients. Four SARS-CoV-2 infected deceased patients were subjected to medicolegal autopsy. Post mortem intervals (PMI) of 1, 4, 9 and 17 days, respectively, were documented. During autopsy, swabs and organ samples were taken and examined by RT-qPCR (real-time reverse transcription-polymerase chain reaction) for the detection of SARS-CoV-2 ribonucleic acid (RNA). Determination of infectivity was performed by means of virus isolation in cell culture. In two cases, virus isolation was successful for swabs and tissue samples of the respiratory tract (PMI 4 and 17 days). The two infectious cases showed a shorter duration of COVID-19 until death than the two non-infectious cases (2 and 11 days, respectively, compared to > 19 days), which correlates with studies of living patients, in which infectivity could be narrowed to about 6 days before to 12 days after symptom onset. Most notably, infectivity was still present in one of the COVID-19 corpses after a post-mortem interval of 17 days and despite already visible signs of decomposition. To prevent SARS-CoV-2 infections in all professional groups involved in the handling and examination of COVID-19 corpses, adequate personal safety standards (reducing or avoiding aerosol formation and wearing FFP3 [filtering face piece class 3] masks) have to be enforced for routine procedures.
SARS-CoV-2(严重急性呼吸综合征冠状病毒 2)在存活患者中的传染性持续时间已被划定。相比之下,尸体中 SARS-CoV-2 的潜在传染性及其在死后情况下的持续时间仍有待阐明。本研究旨在调查已死亡的 COVID-19(冠状病毒病)患者的传染性及其持续时间。对 4 名 SARS-CoV-2 感染的已故患者进行了法医解剖。记录的死后间隔(PMI)分别为 1、4、9 和 17 天。在解剖过程中,采集拭子和器官样本,并通过 RT-qPCR(实时逆转录-聚合酶链反应)检测 SARS-CoV-2 核糖核酸(RNA)。通过细胞培养中的病毒分离来确定传染性。在 2 例病例中,呼吸道的拭子和组织样本的病毒分离成功(PMI 为 4 和 17 天)。这 2 例感染病例的 COVID-19 持续时间比另外 2 例非感染病例更短(分别为 2 天和 11 天,而另外 2 例为 >19 天),这与对存活患者的研究结果一致,在这些研究中,传染性可缩小到症状出现前约 6 天至 12 天后。值得注意的是,在死后间隔 17 天后,一具 COVID-19 尸体中仍然存在传染性,尽管已经出现明显的分解迹象。为了防止所有涉及处理和检查 COVID-19 尸体的专业人员感染 SARS-CoV-2,必须对常规程序实施足够的个人安全标准(减少或避免气溶胶形成,并佩戴 FFP3 [过滤面罩 3 级] 口罩)。